Medtronic’s new insulin pump, the MiniMed 640G, has been approved for use in Australia with other markets around the world expected to follow. The advanced technology mimics human pancreatic function, and Medtronic is calling the launch a breakthrough towards the development of an artificial pancreas.

The MiniMed 640G is equipped with the Bayer CONTOUR NEXT LINK 2.4 blood glucose meter that feeds readings into a Bolus Wizard calculator to reduce the risk of manual error, according to a recent press release from Medtronic. Additionally, Medtronic’s SmartGuard technology stabilizes blood glucose by starting and stopping the insulin pump as needed.

Click here to read the full article.